Hemoglobin drop following postpartum hemorrhage.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 12 2020
Historique:
received: 19 01 2020
accepted: 27 10 2020
entrez: 10 12 2020
pubmed: 11 12 2020
medline: 1 5 2021
Statut: epublish

Résumé

Postpartum hemorrhage (PPH) is defined as blood loss of ≥ 500-1000 ml within 24 h after delivery. Yet, assessment of blood loss is imprecise. The present study aimed to profile the hemoglobin (Hb) drop after vaginal delivery with versus without PPH. This was a secondary analysis of a prospective cohort study of women who delivered vaginally. Women were included if complete blood counts (CBC) before and after delivery were taken until stabilization (N = 419). Women were categorized into the PPH group and controls, for whom post-delivery CBCs were performed due to indications unrelated to bleeding. The PPH patients were then classified as either overt or occult PPH (symptoms related to hypovolemia without overt bleeding) subgroups. The primary endpoint was mean Hb drop after delivery. One hundred and ten (26%) and 158 (38%) women presented with overt PPH or occult PPH, respectively; 151 (36%) women were included in the control group. Mean Hb decrease from baseline was 3.0 ± 1.6, 2.0 ± 1.4 and 0.9 ± 1.0 g/dl, respectively (p < 0.0001). In all groups, maximal rate of Hb decline was in the first 6-12 h postpartum and plateaued after 24-48 h. At 48 h post-delivery, 95% and 86% of women who had dropped to Hb ≤ 9.5 and < 7 g/dl, respectively, reached those thresholds. Taken together, an Hb decrease ≥ 2 g/dl was consistent with PPH diagnosis and should be followed for at least 48 h after delivery.

Identifiants

pubmed: 33298992
doi: 10.1038/s41598-020-77799-0
pii: 10.1038/s41598-020-77799-0
pmc: PMC7725815
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21546

Références

Arch Gynecol Obstet. 2011 Jun;283(6):1207-13
pubmed: 20508942
Turk J Obstet Gynecol. 2015 Sep;12(3):173-181
pubmed: 28913064
Am J Obstet Gynecol. 2019 Jul;221(1):19-29.e3
pubmed: 30578747
BJOG. 2017 Apr;124(5):e106-e149
pubmed: 27981719
Obstet Gynecol. 1991 Jan;77(1):69-76
pubmed: 1984230
Int J Nurs Stud. 2015 Dec;52(12):1798-803
pubmed: 26233835
BJOG. 2006 Aug;113(8):919-24
pubmed: 16907938
Sci Rep. 2019 May 24;9(1):7810
pubmed: 31127175
Int J Obstet Anesth. 2009 Oct;18(4):320-7
pubmed: 19733052
Obstet Gynecol. 2017 Oct;130(4):e168-e186
pubmed: 28937571
Int J Obstet Anesth. 2015 Feb;24(1):8-14
pubmed: 25433576
J Perinat Med. 2011 Mar;39(2):113-21
pubmed: 21070128
Cochrane Database Syst Rev. 2014 Feb 13;(2):CD003249
pubmed: 24523225
Am J Obstet Gynecol. 2010 Apr;202(4):400.e1-5
pubmed: 20035920
Am J Epidemiol. 2002 Nov 15;156(10):903-12
pubmed: 12419762

Auteurs

Enav Yefet (E)

Department of Obstetrics and Gynecology, Emek Medical Center, Yitzhak Rabin Boulevard 21, Afula, 1834111, Israel. enavy1@gmail.com.
Department of Obstetrics and Gynecology, Baruch Padeh Medical Center Poriya, Tiberias, Israel. enavy1@gmail.com.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel. enavy1@gmail.com.

Avishag Yossef (A)

Department of Obstetrics and Gynecology, Emek Medical Center, Yitzhak Rabin Boulevard 21, Afula, 1834111, Israel.

Abeer Suleiman (A)

Department of Obstetrics and Gynecology, Emek Medical Center, Yitzhak Rabin Boulevard 21, Afula, 1834111, Israel.
Department of Obstetrics and Gynecology, Holy Family Hospital, Nazareth, Israel.

Aliza Hatokay (A)

Department of Obstetrics and Gynecology, Emek Medical Center, Yitzhak Rabin Boulevard 21, Afula, 1834111, Israel.

Zohar Nachum (Z)

Department of Obstetrics and Gynecology, Emek Medical Center, Yitzhak Rabin Boulevard 21, Afula, 1834111, Israel.
Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH